Stay updated on Durvalumab vs Placebo in Early NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab vs Placebo in Early NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 04 11 7 has been updated to 06 06 8 on the webpage, indicating a recent change in the Medical and healthcare-related publications and documentation content.
    Difference
    1.0%
    Check dated 2024-06-06T14:29:52.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 6 to 7, indicating an update in the number of certain medical or healthcare-related publications or documentation. This change may reflect new information or additional studies being added to the database.
    Difference
    0.3%
    Check dated 2024-05-22T21:09:51.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:21:51.000Z thumbnail image

Stay in the know with updates to Durvalumab vs Placebo in Early NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.